1.Arzneimittel Forschung/Drug research 1986 36(2)，p291-303.
2.The use of antithrombotic drugs in artery disease
3. Jonassen IB, Havelund S, Ribel U, et al. Insulin Degludec is a new generation ultra-long acting basal insulin with a unique mechanism of protraction based on multi-hexamer ormation [J]. Diabetes, 2010, 59(Suppll): All(39-OR).
4.Korsatko S, Deller S, Zahiragic S, et al. Ultra-long-acting insulin degludec: two different formulations (U100 and U200) are bioequivalent and show similar pharmacodynamics [abstract no. 2349-PO]. Diabetes. 2011;60 Suppl:A624.
5.Technology Reports of the Osaka University, , vol. 7, p. 177,182。
[更多]
渝公網安備 50010802001068號
